TRT Clinics Are Selling You Hormonal Chaos

The liver makes IGF-1. That sentence sounds simple, but it is the entire reason this article exists, because most people receiving peptide protocols from TRT clinics have never been told what that actually means for their hormones or their money.

Here is the full chain so you have the map before we zoom in.

Your pituitary gland releases something called growth hormone, which is the signal your body uses to trigger tissue repair, muscle protein synthesis, and metabolic function throughout the day. That growth hormone travels to the liver, where the liver converts it into something called IGF-1, which stands for insulin-like growth factor 1 and is the molecule that actually does most of the work people credit to growth hormone itself. The growth hormone is the message. The IGF-1 is the execution.

Now here is where estrogen enters the picture, and this is the part almost nobody talks about.

Estrogen is not just a female hormone sitting in the background doing nothing in male physiology. Estrogen is one of the primary regulators of how efficiently the liver converts growth hormone into IGF-1. When estrogen levels are in a healthy range in a man, the liver is primed and responsive. When estrogen drops, that conversion slows down meaningfully, which means your growth hormone signal can be firing perfectly and your IGF-1 output still tanks, not because of a growth hormone problem, but because the liver factory does not have the materials it needs to do the job.

That mechanism is the crack in the foundation of most TRT clinic protocols, and once you see it, the whole business model becomes legible.

When a man goes on testosterone, his estrogen rises because testosterone aromatizes, meaning it converts into estradiol through an enzyme called aromatase. The rise in estrogen is not a side effect in the broken sense. It is a physiological response that, in most men, is part of how testosterone produces its effects on bone density, cardiovascular health, libido, and the IGF-1 pathway we are talking about. The estrogen rising is the system working.

But TRT clinics have built an entire treatment philosophy around suppressing that estrogen as aggressively as possible, because patients come in reporting bloating, water retention, or mood changes, and the clinic wants a simple fix to sell. That fix is an aromatase inhibitor, something called anastrozole, which is a drug designed to block the conversion of testosterone to estrogen and was originally developed for postmenopausal women with estrogen-receptor-positive breast cancer.

When a man takes anastrozole, his estrogen does not just decrease slightly and stabilize. Estrogen is extremely sensitive to aromatase inhibition and the dosing is difficult to titrate, so what tends to happen in practice is that estrogen crashes. Not normalizes. Crashes.

Now the liver is not getting the estrogen signal it needs, so IGF-1 production falls. The patient feels worse, not better. Energy is low, joints ache, mood is flat, libido is gone, and the gains from testosterone they were promised have stalled or reversed. They go back to the clinic and report these symptoms.

And this is where the business model reveals itself.

The clinic looks at the symptom picture and, rather than connecting the crash to the anastrozole they prescribed, they run an IGF-1 panel, see the number is low, and prescribe exogenous IGF-1 or a peptide designed to stimulate IGF-1 production. They have just sold a solution to a problem they created. And the patient, who has no reason to distrust the chain of reasoning, pays for the additional prescription and thinks the clinic is being thorough.

To be precise about what exogenous IGF-1 actually is: it is a recombinant protein that bypasses the entire growth hormone to liver to IGF-1 pathway and delivers the downstream signal directly. In medicine, this has a legitimate use case, and it is so narrow that it is worth being specific. Recombinant IGF-1, sold as mecasermin, is approved for children with severe primary IGF-1 deficiency caused by mutations that make their cells unable to respond to growth hormone at all. This is called Laron syndrome. It affects roughly one in a million people. The prescribing guidelines exist for a population that cannot produce IGF-1 no matter how well their hormonal axis functions.

When a TRT clinic prescribes IGF-1 to a man whose liver is perfectly capable of making it, they are treating a lab number, not a disease. And the lab number is low because they crashed his estrogen with a drug he probably did not need in the first place.

The practical sequence, laid out plainly: testosterone goes up, estrogen goes up, anastrozole is prescribed, estrogen crashes, IGF-1 falls, IGF-1 is prescribed. Each step creates the justification for the next purchase. That is not a care protocol. That is a dependency loop.

The correct intervention at step two is almost always to do less, not more. Most men on TRT whose estrogen rises are experiencing a normal physiological response that does not require pharmaceutical intervention. The research on estradiol in men consistently shows that the symptoms most clinics attribute to high estrogen, water retention, mood instability, gynecomastia at clinical levels, occur at estradiol values significantly higher than where most men actually land. For the majority of men, letting estrogen sit in its natural range while on testosterone preserves the liver's ability to convert growth hormone to IGF-1, preserves bone density, protects cardiovascular function, and does not require a second or third prescription to manage the fallout.

If your IGF-1 is low and you are on testosterone with well-managed estrogen and your pituitary axis is intact, the question is not which IGF-1 peptide to add. The question is what is suppressing the conversion, and whether the treatments you are already on are the cause.

The liver does not need help making IGF-1. It needs the right hormonal environment to do what it already knows how to do. Selling you something to fix what your own treatment broke is not medicine.

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness